Defining "therapeutic" cells as well as establishing cell targeting and tracking technology for the treatment of myocardial infarction and atherosclerosis.

定义“治疗”细胞并建立细胞靶向和追踪技术来治疗心肌梗塞和动脉粥样硬化。

• 批准号: nhmrc : 1070860
• 负责人: Prof Karlheinz Peter
• 金额: $ 44.32万
• 依托单位: Baker IDI Heart and Diabetes Institute
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/defining-therapeutic-cells-infarction-atherosclerosis/455442
• 关键词: Defining; therapeutic; cells; well; establishing

Regenerative cell therapy holds great promise for many diseases. However, studies so far such as preventing and treating heart attacks, often showed limited success. We will address the current three limitations of regenerative cell therapy: 1) Identify the beneficial “therapeutic” cell type. 2) Develop a technology that selectively delivers cells to the area of need. 3) Develop cell tracking technology. This study has the potential to provide major advances in regenerative cell therapy.

再生细胞疗法对许多疾病有很大的希望。然而，迄今为止的研究，如预防和治疗心脏病发作，往往显示出有限的成功。我们将解决目前再生细胞疗法的三个局限性：1）确定有益的“治疗”细胞类型。2)开发一种技术，选择性地将细胞输送到需要的区域。3)开发细胞追踪技术。这项研究有可能为再生细胞治疗提供重大进展。